Skip to main content
editorial
. 2022 Apr 30;3:12. doi: 10.21037/tbcr-22-13

Figure 1.

Figure 1

Enhanced therapy after adjuvant therapy of TNBC. TNBC, triple negative breast cancer; BRCA, breast cancer susceptibility gene; PARPi, poly-ADP-ribose polymerase inhibitor.